BRIEF published on 06/05/2026 at 22:20, 1 month 8 days ago Monthly publication of Nanobiotix voting rights Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
BRIEF published on 06/02/2026 at 22:35, 1 month 11 days ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
BRIEF published on 06/02/2026 at 22:35, 1 month 11 days ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
PRESS RELEASE published on 06/02/2026 at 22:30, 1 month 11 days ago Nanobiotix Provides First Quarter 2026 Operational and Financial Update Nanobiotix provides operational and financial update for Q1 2026, including successful fundraising and clinical study advancements in cancer treatment Cancer Treatment Clinical Study Financial Update NANOBIOTIX Q1 2026
BRIEF published on 06/02/2026 at 08:35, 1 month 12 days ago Nanobiotix joins the Euronext Tech Leaders index Innovation Investors Biotechnology NANOBIOTIX Euronext Tech Leaders
BRIEF published on 06/02/2026 at 08:35, 1 month 12 days ago Nanobiotix Joins Euronext Tech Leaders Index Innovation Biotechnology Healthcare NANOBIOTIX Euronext Tech Leaders
PRESS RELEASE published on 06/02/2026 at 08:30, 1 month 12 days ago Nanobiotix Joins the Euronext Tech Leaders Index Nanobiotix joins the Euronext Tech Leaders Index, a move recognizing its contributions to nanotechnology in healthcare innovation and expanding treatment options for cancer patients Cancer Treatment Healthcare Innovation Nanotechnology NANOBIOTIX Euronext Tech Leaders Index
BRIEF published on 05/26/2026 at 23:04, 1 month 18 days ago NANOBIOTIX Completes Global Offering with $100 Million Proceeds Securities Biotechnology Investment Global Offering NANOBIOTIX
PRESS RELEASE published on 05/26/2026 at 22:59, 1 month 18 days ago NANOBIOTIX Announces Closing of Global Offering Nanobiotix closes global offering with total gross proceeds of $100 million. Proceeds to fund development and corporate purposes. Ordinary shares and ADSs issued Development ADSs Proceeds Global Offering NANOBIOTIX
BRIEF published on 05/22/2026 at 22:20, 1 month 22 days ago NANOBIOTIX raises $100 million through a global offering Biotechnology Fundraising Ads Cancer NANOBIOTIX
Published on 07/14/2026 at 14:00, 1 hour 8 minutes ago First Canadian Graphite Appoints Tony La Mantia to Advisory Board
Published on 07/14/2026 at 13:30, 1 hour 38 minutes ago ESGold Executes Definitive Agreement to Acquire Strategic Montauban Claims
Published on 07/14/2026 at 13:00, 2 hours 8 minutes ago Eagle Plains and Pacific Bay Minerals Execute Option Agreement for Haskins Critical Minerals Project, British Columbia
Published on 07/14/2026 at 13:00, 2 hours 8 minutes ago Abasca Increases Loki Flake Graphite Resource and Confirms Second Mineralized Trend at Thor Zone
Published on 07/14/2026 at 13:00, 2 hours 8 minutes ago INEO Provides Preliminary Q4 Revenue and Order Backlog Update
Published on 07/14/2026 at 14:52, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 07/14/2026 at 14:52, 16 minutes ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc.
Published on 07/13/2026 at 18:00, 21 hours 8 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 07:30, 1 day 7 hours ago Disclosure of transactions in own shares from July 6 to July 10, 2026
Published on 07/10/2026 at 18:00, 3 days 21 hours ago Half-year liquidity contract statement for CEGEDIM
